2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Blood Cancer
Hematologic malignancies, collectively known as blood cancer, encompass a spectrum of diseases affecting the blood, bone marrow, and lymphatic system. This intricate field of cancer research delves into unraveling the underlying mechanisms driving these diseases, revolutionizing diagnostic techniques, and pioneering tailored therapeutic interventions. Breakthroughs in genomic analysis have unveiled pivotal genetic aberrations fueling blood cancers, paving the way for precision medicine approaches. Immunotherapies, such as CAR-T cell therapy, present promising avenues by leveraging the body's immune prowess against malignant cells. Beyond conventional treatments, ongoing clinical investigations explore innovative strategies, including targeted pharmacotherapies and stem cell transplants. Through synergistic collaborations across disciplines, researchers forge ahead in their quest for transformative advancements, offering renewed hope for individuals grappling with blood cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China